| Molecular formula | C62H98N16O22 |
|---|
| Molecular weight | 1419.5 g/mol |
|---|
| Registered trials | 2 |
|---|
| PubChem CID | 9941957 |
|---|
Regulatory Status
BPC-157 has no FDA-approved label and is not authorized for any medical use in the United States. It exists only as an unapproved research compound, meaning any use outside a registered trial falls outside regulatory oversight.
What BPC-157 Is
BPC-157 is a synthetic peptide with the molecular formula C62H98N16O22 and a molecular weight of about 1,419.5 (PubChem CID 9941957). Because no FDA label exists for this compound, there is no established mechanism of action, approved indication, or official dosing information to reference.
Clinical Trial Footprint
Two trials involving BPC-157 are currently registered. One is recruiting participants to evaluate its use in acute hamstring muscle strain repair. The other, an earlier safety and pharmacokinetics trial, is listed with an unknown status. Together these represent the limited, early-stage research record for this compound.
FAQ
No. BPC-157 has no FDA-approved label and is classified as an unapproved research compound. There is no official indication, dosing guidance, or safety label associated with it.
BPC-157 is a synthetic peptide with the molecular formula C62H98N16O22 and a molecular weight of approximately 1,419.5. It is catalogued in PubChem under CID 9941957.
Two trials involving BPC-157 are currently registered. One is recruiting participants to study its role in acute hamstring muscle strain repair, while an earlier safety and pharmacokinetics trial is listed with an unknown status.
No adverse event reporting data is currently available for this compound. Safety information is limited to what may emerge from the small number of registered clinical trials.
Because BPC-157 is unapproved and lacks an FDA label, it has no sanctioned use outside registered research trials. Any other use falls outside regulatory oversight and established safety review.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-08-03